Search

Search Constraints

You searched for: Author/Creator Beukinga, Ingrid

Search Results

2. Analytical and clinical validation of an ELISA for specific SARS‐CoV‐2 IgG, IgA, and IgM antibodies. Issue 2 (27th July 2020)

3. Assessment 2 months after the administration of a 3rd dose mRNA: a new variant-adapted vaccine is expected. Issue 4 (April 2022)

5. Circulating (CD3−CD19+CD20−IgD−CD27highCD38high) Plasmablasts: A Promising Cellular Biomarker for Immune Activity for Anti-PLA2R1 Related Membranous Nephropathy?. (14th July 2016)

6. Development and implementation of a RT‐qPCR extraction‐free protocol for the detection of SARS‐CoV‐2 and impact on the turn‐around‐time. Issue 4 (22nd January 2021)

7. Efficacy comparison of three rapid antigen tests for SARS‐CoV‐2 and how viral load impact their performance. Issue 10 (4th June 2021)

8. Immunogenicity of mRNA-1273 COVID vaccine after 6 months surveillance in health care workers; a third dose is necessary. Issue 5 (November 2021)

9. Large-scale, molecular and serological SARS-CoV-2 screening of healthcare workers in a 4-site public hospital in Belgium after COVID-19 outbreak. Issue 1 (January 2021)

10. Reactogenicity, safety and antibody response, after one and two doses of mRNA-1273 in seronegative and seropositive healthcare workers. Issue 2 (August 2021)